We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Cyclopharm is a medical devices business based in Australia. Cyclopharm shares (CYC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Cyclopharm has a trailing 12-month revenue of around $20 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
| 52-week range | $0.95 - $2.1331 |
|---|---|
| 50-day moving average | $1.2927 |
| 200-day moving average | $1.6062 |
| Target price | $1.48 |
| PE ratio | N/A |
| Dividend yield | $0.01 (0.96%) |
| Earnings per share (TTM) | $-0.056 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.055
| 1 week (2022-06-22) | -1.40% |
|---|---|
| 1 month (2022-05-30) | -18.85% |
| 3 months (2022-03-30) | -35.47% |
| 6 months (2021-12-30) | -35.67% |
| 1 year (2021-06-30) | -37.94% |
|---|---|
| 2 years (2020-06-30) | -24.64% |
| 3 years (2019-06-28) | -28.23% |
| 5 years (2017-06-29) | 22.67% |
| Revenue TTM | $20 million |
|---|---|
| Gross profit TTM | $15 million |
| Return on assets TTM | -6.94% |
| Return on equity TTM | -16.75% |
| Profit margin | -25.21% |
| Book value | 0.461 |
| Market capitalisation | $98.5 million |
TTM: trailing 12 months
We're not expecting Cyclopharm to pay a dividend over the next 12 months.
Cyclopharm 's shares were split on a 1:5 basis on 28 May 2012. So if you had owned 5 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Cyclopharm shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Cyclopharm shares which in turn could have impacted Cyclopharm 's share price.
Over the last 12 months, Cyclopharm 's shares have ranged in value from as little as $0.95 up to $2.1331. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Cyclopharm 's is 0.5537. This would suggest that Cyclopharm 's shares are less volatile than average (for this exchange).
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
